Dr. Ellen Scherl is the Research Director and Founding Director of the Jill Roberts Center for Inflammatory Bowel Disease (IBD), Weill Cornell Medicine. She says, it’s time for gastroenterologists to approach GI care comprehensively and reclaim their role as healers.
Browsing: Covid19
Joe Rubinsztain, M.D is the CEO and Co-Founder at ChronWell. In this future-oriented interview, Dr. Rubinsztain walks us through how ChronWell works and their progress during COVID-19.
John Allen, M.D is the Chief Clinical Officer of the University of Michigan Medical Group and is also on the board of Allina Health. This interview is so insightful that it’ll help you make several business and personal decisions for the long haul.
Christopher Fourment, M.D is the President and CEO of Clinical Research Strategy Group and Precision Research (Texas). In this interview, you’ll learn why Dr. Fourment chose to focus on clinical research as a career path.
George “G.B.” Pratt is the Founder and CEO of ModifyHealth. The company recently raised $2 million in Series A funding – right in the middle of the pandemic. In this interview, you’ll learn more about ModifyHealth’s business model. A big question GB reflects on is whether ModifyHealth goes against the grain of today’s healthcare model.
In this video, Dr. Don Lazas shares his insights on how GI physicians can take the spirit of entrepreneurship beyond private practice.
In this interview, with Dr. Narayanachar Murali, Dr. Don Lazas and Dr. Chris Fourment, you’ll learn three different perspectives on clinic trials/research as an ancillary in a GI practice. We’ll explore the pros/cons, costs, risks, and operating models.
Dr. Latha Alaparthi is from Physician Alliance of Connecticut (PACT) and Gastroenterology Center of Connecticut (GCC). In this interview, learn how a multispecialty GI group made a decision to ally with a regional hospital. Understand what steps PACT GCC took to navigate COVID-19 and what they are doing now to continue endoscopies safely.
In the interview’s second part, Dr. Weinstein talks about how many aspects of the medical practice can be done remotely. He reflects on the future of GI post COVID, his experiences with the giants of gastroenterology (e.g. Dr. Gene Overholt, the father of endoscopy) and what must fellows in GI must focus on.
Dr. Michael Weinstein is the President & CEO of Capital Digestive Care, the largest gastroenterology group in the Mid-Atlantic states. In this interview, Dr. Weinstein outlines the benefits of their MSO to private GI practices. Is there going to be a cash payout during transaction? How does it differ from private equity?